2,5-Dioxopyrrolidin-1-yl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetate, 95.0%, 5g

4-Bromo-2-chloro-5-methylbenzoic acid, 98%, 250mg

(S)-1-Cyclohexylethanamine hydrochloride, 97%, 1g

Oxyde de titane(IV), ROTI®nanoMETIC, min 99,9 %, 4-8 nm, 10 g, emballage en verre

2-Bromo-1-(2,3-dihydrobenzo[1,4]-dioxin-6-yl)ethanone, 95.0%, 1g

(S)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-1-(5-methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoyl)pyrrolidin-3-one, 100mg

(6-BROMOPYRIDIN-2-YL)(CYCLOPENTYL)METHANONE, 95.0%, 1g

butyl[(2-fluorophenyl)methyl]amine hydrochloride, 95.0%, 1g

(1-oxo-4-phenyl-2(1H)-phthalazinyl)acetic acid hydrate, 95.0%, 5g

4-Amino-3,5-dichlorobenzylamine, 90.0%, 5g

2-(2-Methoxyphenyl)acetyl chloride, 95.0%, 2g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-iodobenzyl)pyrrolidine-2-carboxylic acid, 97%, 1g

4-Chloro-3-(pyridin-2-yl)aniline, 95.0%, 250mg